Key result
Caveolin-1 decreases in NAFLD hepatocytes and enhances hepatic iron storage via the ferritin pathway.
Why the study?
Although Cav-1 is known to protect hepatocytes and mediate hepatic iron metabolism, the specific mechanisms underlying its regulation of iron metabolism in NAFLD remained unclear.
Does Caveolin-1 regulate iron and lipid metabolic homeostasis in nonalcoholic fatty liver disease?
Population
Hepatocyte-specific Cav-1 overexpression/knockout mice, cellular models, and NAFLD patients and healthy volunteers
Comparison
Cav-1 overexpression, knockout, or knockdown vs controls under normal, high-fat, or high-iron conditions
Design
In vivo and in vitro experimental study with a human cross-sectional cohort
Authors
Loading...
Caveolin-1 downregulation may link iron overload to NAFLD progression; hypothesis-generating in animal models and requires human validation.
Does Caveolin-1 regulate iron and lipid metabolic homeostasis in nonalcoholic fatty liver disease?
p-value: p=<0.05
Caveolin-1 is a critical regulator of iron and lipid metabolic homeostasis, offering a potential target for predicting and protecting against NAFLD development.
Guang-hui et al. (2023) studied Nonalcoholic fatty liver disease (n=70). Caveolin-1 (Cav-1) vs. Healthy controls / Normal expression was evaluated on Expression of Cav-1 in NAFLD hepatocytes and correlation with iron metabolism (p=<0.05). Caveolin-1 expression was significantly decreased in NAFLD hepatocytes (P < 0.05), and it enhanced hepatic iron storage capacity by activating the ferritin light/heavy chain pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: